Marine Phytoplankton Improves Exercise Recovery in Humans and Activates Repair Mechanisms in Rats

Int J Sports Med. 2021 Nov;42(12):1070-1082. doi: 10.1055/a-1320-1061. Epub 2020 Dec 22.

Abstract

This study investigated the effects of marine phytoplankton supplementation on 1) perceived recovery and ground reaction forces in humans following a non-functional overreaching resistance-training program and 2) myogenic molecular markers associated with muscle cell recovery in a rat model. In the human trial, a 5-week resistance-training program with intentional overreaching on weeks 2 and 5 was implemented. Results indicate that marine phytoplankton prompted positive changes in perceived recovery at post-testing and, while both marine phytoplankton and placebo conditions demonstrated decreased peak and mean rate of force development following the overreaching weeks, placebo remained decreased at post-testing while marine phytoplankton returned to baseline levels. In the rat model, rats were divided into four conditions: (i) control, (ii) exercise, (iii) exercise + marine phytoplankton 2.55 mg·d-1, or (iv) exercise+marine phytoplankton 5.1 mg·d-1. Rats in exercising conditions performed treadmill exercise 5 d·wk-1 for 6 weeks. Marine phytoplankton in exercising rats increased positive and decrease negative myogenic factors regulating satellite cell proliferation. Taken together, marine phytoplankton improved perceptual and functional indices of exercise recovery in an overreaching human model and, mechanistically, this could be driven through cell cycle regulation and a potential to improve protein turnover.

Publication types

  • Randomized Controlled Trial

MeSH terms

  • Animals
  • Biomarkers / blood
  • Cell Count
  • Cell Cycle / physiology
  • Double-Blind Method
  • Female
  • Humans
  • Male
  • Muscle Development / physiology*
  • Muscle Strength / physiology*
  • Muscle, Skeletal / physiology*
  • Physical Conditioning, Animal
  • Phytoplankton*
  • Rats
  • Rats, Wistar
  • Resistance Training / methods*

Substances

  • Biomarkers

Grants and funding

Funding: Lonza Consumer Health Inc. supplied treatment (Oceanix TM) and placebo conditions, and financially support the study.